Zhang, C.; Huang, X.; Ye, H.; Tang, H.; Huang, M.; Jia, S.; Shao, J.; Wu, J.; Yao, X.
Mechanistic Evaluation of Roxadustat for Pulmonary Fibrosis: Integrating Network Pharmacology, Transcriptomics, and Experimental Validation. Pharmaceuticals 2026, 19, 179.
https://doi.org/10.3390/ph19010179
AMA Style
Zhang C, Huang X, Ye H, Tang H, Huang M, Jia S, Shao J, Wu J, Yao X.
Mechanistic Evaluation of Roxadustat for Pulmonary Fibrosis: Integrating Network Pharmacology, Transcriptomics, and Experimental Validation. Pharmaceuticals. 2026; 19(1):179.
https://doi.org/10.3390/ph19010179
Chicago/Turabian Style
Zhang, Congcong, Xinyue Huang, Huina Ye, Haidong Tang, Minwei Huang, Shu Jia, Jingping Shao, Jingyi Wu, and Xiaomin Yao.
2026. "Mechanistic Evaluation of Roxadustat for Pulmonary Fibrosis: Integrating Network Pharmacology, Transcriptomics, and Experimental Validation" Pharmaceuticals 19, no. 1: 179.
https://doi.org/10.3390/ph19010179
APA Style
Zhang, C., Huang, X., Ye, H., Tang, H., Huang, M., Jia, S., Shao, J., Wu, J., & Yao, X.
(2026). Mechanistic Evaluation of Roxadustat for Pulmonary Fibrosis: Integrating Network Pharmacology, Transcriptomics, and Experimental Validation. Pharmaceuticals, 19(1), 179.
https://doi.org/10.3390/ph19010179